Skip to main content

Connecting Healthcare Professionals to Scientific Information

UCBCOMPASS® provides scientific education and
medical information on UCB medicines used to treat
certain immune-mediated inflammatory conditions
and rare diseases.

 

Search Congress Materials
Announcements

RHEUMATOLOGY

BIMZELX® (bimekizumab-bkzx) is now FDA approved for the treatment of adults with active PsA, nr-axSpA, and AS. See the phase 3 clinical trial data in Publications.

 

UCB continues to proactively monitor the COVID-19 situation. To learn more about UCB's preparedness, click here.

RHEUMATOLOGY

The Women's Health Fellowship Program application is now accepting applications for the 2025 - 2026 fellowship year. Learn More

Listen to Podcasts

Gain insights as scientists, medical experts, and patients discuss advances and unmet needs in inflammatory autoimmune conditions.

/disease-education/scientific-education-podcasts
Find Publications

Review the latest UCB research, including original articles, from peer-reviewed sources.

/our-science/publications
Opportunities for Investigators

Submit a study concept, request access to patient-level data from UCB trials, or become a UCB clinical trial investigator.

/our-science/research-support